article · Annales Africaines de Medecine
Transfusion of red cell concentrates (RMCs) is the administration of red blood cells from a donor to a recipient to correct anemia. Despite improvements in blood preservation and treatment techniques in developed countries, the risk of transfusion-related adverse reactions remains significant. In Sub-Saharan Africa (SSA), while haemovigilance is not well organized and the majority of health institutions do not always screen for irregular agglutinins before each blood transfusion. Therefore, the restrictive transfusion policy defined by a transfusion threshold of blood haemoglobin concentration between 7 and 8 g/dl should be in place. Received: March 10th, 2021 Accepted: July 21st, 2021
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4314/aam.v14i4.10
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.